Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Nicola

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|March 28, 2003
Dendritic cellsMassimo Di Nicola, A Massimo Gianni
Current Opinion in Oncology|July 12, 2018
Immunotherapy-based combinations: an updateGiovanni Fucà, Filippo de Braud, Massimo Di Nicola
Frontiers in Immunology|September 22, 2015
Lymphoma Immunotherapy: Current StatusRoberta Zappasodi, Filippo de Braud, Massimo Di Nicola
Tumori|February 25, 2003
[Mesenchymal stem cells: biology and clinical applications]Carmelo Carlo-Stella, Massimo Di Nicola, Massimo A Gianni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Immune Suppression and Response to Ipilimumab: Assessing Risk-to-Benefit RatioAlice Indini, Massimo Di Nicola, Michele Del Vecchio, et al.
Cancers|August 7, 2021
Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against CancerFrancesco Mainini, Francesca De Santis, Giovanni Fucà, et al.
Future Oncology (London, England)|June 21, 2014
Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapyAurora Mirabile, Luigi Celio, Michele Magni, et al.
Current Gene Therapy|October 28, 2005
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphomaPier Adelchi Ruffini, Massimo Di Nicola, Carmelo Carlo-Stella, et al.
Blood|August 2, 2002
Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibodyPaola Matteucci, Michele Magni, Massimo Di Nicola, et al.
Experimental Hematology|May 30, 2007
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress ReagentCristiana Lavazza, Carmelo Carlo-Stella, Massimo Di Nicola, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|March 28, 2003
Dendritic cellsMassimo Di Nicola, A Massimo Gianni
Current Opinion in Oncology|July 12, 2018
Immunotherapy-based combinations: an updateGiovanni Fucà, Filippo de Braud, Massimo Di Nicola
Frontiers in Immunology|September 22, 2015
Lymphoma Immunotherapy: Current StatusRoberta Zappasodi, Filippo de Braud, Massimo Di Nicola
Tumori|February 25, 2003
[Mesenchymal stem cells: biology and clinical applications]Carmelo Carlo-Stella, Massimo Di Nicola, Massimo A Gianni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Immune Suppression and Response to Ipilimumab: Assessing Risk-to-Benefit RatioAlice Indini, Massimo Di Nicola, Michele Del Vecchio, et al.
Cancers|August 7, 2021
Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against CancerFrancesco Mainini, Francesca De Santis, Giovanni Fucà, et al.
Future Oncology (London, England)|June 21, 2014
Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapyAurora Mirabile, Luigi Celio, Michele Magni, et al.
Current Gene Therapy|October 28, 2005
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphomaPier Adelchi Ruffini, Massimo Di Nicola, Carmelo Carlo-Stella, et al.
Blood|August 2, 2002
Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibodyPaola Matteucci, Michele Magni, Massimo Di Nicola, et al.
Experimental Hematology|May 30, 2007
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress ReagentCristiana Lavazza, Carmelo Carlo-Stella, Massimo Di Nicola, et al.
Pageof 10